ALKERMES | Należności Handlowe



Trade Debtors Zmiana Data
AbbVie USD 10.92B 553M 2024-12
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
ALKERMES USD 394.72M 24.54M 2024-12
Amgen USD 6.78B 535M 2024-12
Biogen USD 1.87B 119.3M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
Intra Cellular Therapies USD 166.5M 20.89M 2024-12
Ionis Pharmaceuticals USD 92.19M 74.26M 2024-12
J&J USD 14.84B 1.33B 2024-12
Malin Corporation EUR 200K 6.3M 2024-06
Merck USD 11.12B 1.06B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Otsuka Holdings JPY 518.82B 43.32B 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



ALKERMES Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.